Why "Section 42"?

Sections 42DL and 42DLB of the Therapeutic Goods Act 1989 are the provisions that make advertising prescription medicines — including medicinal cannabis — to the Australian public unlawful. They're the sections printed on the infringement notices. We named the business after the rule because that's what we audit against: the published law and guidance, methodically, page by page.

Section 42 Compliance exists because the sector had exactly two options: engage a specialist law firm at $400–$800 per hour, or hope. We built a third option — a productized, fixed-price review with a 20-rule engine derived from the Act, the Advertising Code, current TGA and Ahpra guidance, and the documented patterns in every published enforcement action.

What we are

An independent compliance review service. We audit public marketing, score risk, reference every finding to the rule it engages, and hand you the fix. Reports are written to be actioned by your team the same day, and to be shown to boards, insurers and acquirers as evidence of governance.

What we are not

We are not a law firm and reports are not legal advice. We are not affiliated with the TGA or Ahpra. And we are deliberately not a cannabis brand — you'll find no leaves, no green branding and no product talk here, because a compliance auditor's own marketing should model the standard.

How we work

Entirely async and email-only. Order online, receive the report in your inbox, ask follow-ups by email with responses inside two business days. It keeps our prices fixed and our turnarounds honest.